aon glp-1 | Professional Services Managing Obesity Crisis with GLP-1
Description
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
At Sunrise Wellness, we offer weight loss medication Semaglutide and Tirzepatide as well as 3D Body Scanning and Customized Meal Plans.
Explore the science behind natural alternatives, their effectiveness, and what experts say about managing hunger naturally.
Results The primary analysis assessing the association between GLP-1 RA use and GRC or aspiration events included 20 retrospective studies with a total of 207,708 patients (23,366 GLP-1 RA users)
Weighless MD is bringing dietitians and functional nutritionists together to collaborate on strategic weight loss and wellness programs.
Find out how Ozempic affects your birth control.
